Picture of Strides Pharma Science logo

STAR — Strides Pharma Science News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees

May 18 (Reuters) - Strides Pharma Science Ltd SRID.NS:

STRIDES PHARMA SCIENCE MARCH-QUARTER CONSOL NET PROFIT 1.27 BILLION RUPEES

STRIDES PHARMA SCIENCE MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 13.23 BILLION RUPEES

STRIDES PHARMA SCIENCE LTD - RECOMMENDS FINAL DIVIDEND OF 5 RUPEES PER SHARE FOR FY2026

Source text: ID:nnAZN4SWWQY

Further company coverage: SRID.NS

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Strides Pharma Science

See all news